NCT03153098

An Evaluation of the Active Herts Physical Activity Programme

Status unknown Last updated 15 May 2017

What this trial tests

trial testing Active Herts in Physical Activity in 739 participants. Status unknown.

Timeline

7 January 2016

Primary endpoint
7 January 2019

7 January 2019

Quick facts

Lead sponsor	University of East Anglia
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	739
Start date	7 January 2016
Primary completion	7 January 2019
Estimated completion	7 January 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

• Active Herts

Conditions studied

• Physical Activity — all drugs for Physical Activity →

Sponsor

University of East Anglia

Who can join

16 and older, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a high prevalence of inactive adults in the United Kingdom (UK), many of whom suffer from conditions such as diabetes, cardiovascular disease, and poor mental health. These problems often co-exist more frequently in areas of higher socio-economic deprivation. There is an ongoing need to test the effectiveness, acceptability, and sustainability of community physical activity interventions. The Active Herts programme is a community physical activity programme aimed at inactive adults aged 16 and over who have one or more risk factors for cardiovascular disease (CVD) and/or a mild to moderate mental health condition. The programme uses the latest evidence-based behaviour change techniques to target physical activity, wellbeing, and key drivers of behaviour from the COM-B ('Capability', 'Opportunity', 'Motivation' and 'Behaviour') model of behaviour change.

This evaluation will follow a mixed-methods longitudinal (baseline, and 3, 6 and 12 month follow-ups) pragmatic observational design. Two types of programme are being delivered, each in a different area. In one, group participants will receive a behaviour change technique booklet, consultations (baseline, and optional at 3, 6, and 12 months), a booster phone call (week 2), motivational text messages (weeks 3, 6, and 12), and signposting to 12 weeks of exercise classes. In the other 'enhanced delivery' group, participants will receive the same but the 12 weeks of exercise will be free and tailored to their needs, and there will be optional exercise 'buddies' available. An outcome evaluation will assess changes in physical activity as the primary outcome, and sporting participation, sitting, wellbeing, psychological capability, and reflective motivation as secondary outcomes. A process evaluation will use both one-to-one interviews and focus groups to explore the views of stakeholders, delivery staff, and participants over three phases (set-up, deviations in the delivery of the intervention, and looking back over the intervention). Economic evaluation will examine the costs of the Active Herts programme against the benefits gained in terms of reduced risk of morbidity from a range of chronic conditions.

This study will measure key drivers of physical activity using up to date behaviour change theory, allowing evaluation of not only whether physical activity has increased but also why. The research will inform the future development of a scalable intervention that can be more robustly tested in a randomised controlled trial.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. How effective is community physical activity promotion in areas of deprivation for inactive adults with cardiovascular disease risk and/or mental health concerns? Study protocol for a pragmatic observational evaluation of the 'Active Herts' physical activity programme.
   Howlett N, Jones A, Bain L, Chater A. · · 2017 · cited 12× · PMID 29175885 · DOI 10.1136/bmjopen-2017-017783
2. Outcome evaluation of Active Herts: A community-based physical activity programme for inactive adults at risk of cardiovascular disease and/or low mental wellbeing.
   Chater AM, Schulz J, Jones A, Burke A, et al · · 2022 · cited 5× · PMID 36159253 · DOI 10.3389/fpubh.2022.903109